Acute tubulo-interstitial nephritis requiring dialysis associated with intermittent rifampicin use: Case report

International Journal of Artificial Organs

Volumn 22, Issue 7, 1999, Pages 477-481

  Gallieni, M ^a,b   Braidotti, P ^a   Cozzolino, M ^a   Romagnoli, S ^a   Carpani, P ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Ospedale San Paolo   (Italy)

Author keywords

Acute renal failure; Biopsy; Dialysis; Hemodialysis; Interstitial nephritis; Rifampicin

Indexed keywords

BIOPSY; PATIENT TREATMENT;

ACUTE RENAL FAILURE; CASE REPORTS; HAEMODIALYSIS; HEPATOTOXICITY; HIGH DOSE; INTERSTITIAL NEPHRITIS; INTERSTITIALS; RENAL FAILURE; RENAL FUNCTIONS; RIFAMPICIN;

DIALYSIS;

CD3 ANTIGEN; CD5 ANTIGEN; CD68 ANTIGEN; DOPAMINE; FUROSEMIDE; NIFEDIPINE; RIFAMPICIN;

ACUTE KIDNEY FAILURE; AGED; ARTICLE; CASE REPORT; DOSE KIDNEY FUNCTION RELATION; DRUG INDUCED DISEASE; DRUG INTERMITTENT THERAPY; FOLLOW UP; HEMODIALYSIS; HUMAN; IMMUNOREACTIVITY; INTERSTITIAL NEPHRITIS; LIVER TOXICITY; MALE; NEPHROTOXICITY; STAPHYLOCOCCUS INFECTION; TUBERCULOSIS;

EID: 0032834368     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139889902200704     Document Type: Article

References (19)

1. Verbist L, Gyselen A. Antituberculous activity of rifampin in vitro and in vivo and the concentrations attained in human blood. Am Rev Resp Dis 1968; 98: 923-32.
2. Tuazon CD, Lin MYC, Sheagren JN. In vifro activity of rifampin alone and in combination with nafcillin and vancomycin against pathogenic strains of Staphylococcus Aureus. Antimicrob Agents Chemoter 1978; 13:759-61.
3. Roos KL, Tunkel AR, Scheid WM. Acute bacterial meningitis in children and adults. In: WM Scheid, RJ Whitley, and DT Durak, (eds). Infections of the central nervous system. New York; Raven, 1991; 335-409.
4. Girling DJ. Adverse reactions to rifampin in anti-tuberculosis regimens. J Antimicrob Chemoter 1977; 3:115-32.
5. Pujet JC, Homberg JC, Decroix G. Sensitivity to rifampicin: incidence, mechanism, and prevention. Br Med J 1974; 2: 415-8.
6. Scheuer PJ, Summerfield JA, Lai S, Sherlock S. Rifampin hepatitis. Lancet 1974; 1:421-5.
7. Izhar M, Magana L. Rifampicin induced acute renal failure. Int J Artif Organs 1999; 22: 474-6.
8. De Vriese AS, Robbrecht DL, Vanholder RC, Vogelaers DP, Lameire NH. Rifampicin-associated acute renal failure: Pathophysiologic, immunologie, and clinical features. Am J Kidney Dis 1998; 31:108-15.
9. Kohler U, Gohara AF, Hamilton WR, Reeves RS. Crescentic fibrillary glomerulonephritis associated with intermittent rifampin therapy for pulmonary tuberculosis. Clin Nephrol 1994;42:263-5.
10. Quinn B, Wall B. Nephrogenic diabetes insipidus and tubulointerstitial nephritis during continuous therapy with rifampicin. Am J Kidney Dis 1989; 14:217-20.
11. Gabow PA, Lacher JW, Neff TA. Tubulointerstitial and glomerular nephritis associated with rifampin. Report of a case. JAMA 1976; 235: 2517-8.
12. Bansal VK, Bennett D, Molnar Z. Prolonged renal failure after rifampin. Am Rev Respir Dis 1977; 116:137-40
13. Neugarten J, Gallo GR, Baldwin DS. Rifampicin-induced nephrotic syndrome and acute interstitial nephritis. Am J Nephrol 1983; 3: 38-42.
14. Lamy P, Cacoub P, Deray G, Baumelou A, Detilleux M. Insufisance rénale aigué et syndrome néphrotique dus à la rifampicine: Polymorphisme de la néphrotoxicité de la rifampicine. Ann Med Interne Paris 1989; 140:323-5.
15. Katz MD, Lor E. Acute interstitial nephritis associated with intermittent rifampin use. Drug Intell Clin Pharm 1986; 20: 789-92
16. Barnes N, Bellamy D, Ireland R, Parsons V, Costello J. Pulmonary tuberculosis complicated by haemophagocytic syndrome and rifampicin-induced tubulointerstitial nephritis. Br J Dis Chest 1984; 78: 395-403.
17. Power DA, Russel G, Smith FW, et al. Acute renal failure due to continuous rifampicin. Clin Nephrol 1983; 20:155-9.
18. Rose BD, Appel GB. Drug-induced acute interstitial nephritis. UpToDate in Medicine. 1998; Vol 6, No.1
19. Truong LD, Eknoyan G. Tubulointerstitial diseases of the kidney. Pathology Case Reviews 1998; 3:169-74